During the past decade, Parexel International conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parexel International" #1 sponsor was "H. Lundbeck A/S" with 3 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parexel International" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Parexel International" are "Healthy Participants" (5 trials), "Healthy Volunteers" (4 trials), "Alzheimer Disease" (2 trials), "Healthy" (2 trials) and "Pharmacokinetics of Isavuconazole" (2 trials). Many other conditions were trialed in "Parexel International" in a lesser frequency.

Most popular intervention types in "Parexel International" are "Drug" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "TAK-418" (2 trials), "AG-221" (1 trials), "CC-90001" (1 trials) and "E2027" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parexel International" are 17 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Parexel International". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Parexel International, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Parexel International, 18 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Parexel International has several departments that took part in Clinical trials: "Parexel Early Phase Unit at Glendale" - 20 trials, "Parexel - Early Phase Clinical Unit" - 10 trials